ClearBridge Investments - NOVOCURE LTD ownership

NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 313 filers reported holding NOVOCURE LTD in Q4 2022. The put-call ratio across all filers is 1.54 and the average weighting 0.2%.

Quarter-by-quarter ownership
ClearBridge Investments ownership history of NOVOCURE LTD
ValueSharesWeighting
Q2 2023$3,316,815
-30.6%
79,923
+0.6%
0.00%
-40.0%
Q1 2023$4,779,290
-16.4%
79,469
+1.9%
0.01%
-16.7%
Q4 2022$5,719,686
-3.7%
77,978
-0.3%
0.01%0.0%
Q3 2022$5,942,000
+9.2%
78,205
-0.1%
0.01%
+20.0%
Q2 2022$5,443,000
-10.8%
78,311
+6.3%
0.01%0.0%
Q1 2022$6,103,00073,6640.01%
Other shareholders
NOVOCURE LTD shareholders Q4 2022
NameSharesValueWeighting ↓
Invus Financial Advisors, LLC 350,884$26,344,0008.01%
HARTLINE INVESTMENT CORP/ 318,109$23,884,0003.27%
Deep Track Capital, LP 550,000$41,294,0002.92%
MORGAN JESS S & CO INC 43,975$3,302,0002.03%
Taylor Frigon Capital Management LLC 46,376$3,482,0001.09%
Darsana Capital Partners LP 258,937$19,441,0000.90%
Private Harbour Investment Management & Counsel, LLC 13,562$1,018,0000.81%
Rhenman & Partners Asset Management AB 120,387$9,610,0000.64%
COURAGE CAPITAL MANAGEMENT LLC 10,000$751,0000.50%
Baillie Gifford 9,615,168$721,906,0000.40%
View complete list of NOVOCURE LTD shareholders